SEARCH

SEARCH BY CITATION

References

  • 1
    Rich L. Search of diagnosic data base. Seattle, Washington; verbal communication, 2007.
  • 2
    Bradley RL, MacEwen EG, Loar AS. Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. J Am Vet Med Assoc 1984;184:460463.
  • 3
    Hutson CA, Willauer CC, Walder EJ, et al. Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: Seven cases (1987–1989). J Am Vet Med Assoc 1992;201:777781.
  • 4
    Fox LE, Rosenthal RC, King RR, et al. Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma. Am J Vet Res 2000;61:791795.
  • 5
    Ogilvie GK, Moore AS, Obradovich JE. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. J Am Vet Med Assoc 1993;202:18391844.
  • 6
    Mauldin GN, Matus RE, Patnaik AK, et al. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. J Vet Intern Med 1988;2:6065.
  • 7
    Buhles WC Jr, Theilen GH. Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma. Am J Vet Res 1973;34:289291.
  • 8
    Postorino-Reeves NCTJ, Withrow SJ. Oral squamous cell carcinoma in the cat. J Am Vet Med Assoc 1993;202:438441.
  • 9
    Bregazzi VS, LaRue SM, Powers BE, et al. Response of feline oral squamous cell carcinoma to palliative radiation therapy. Vet Radiol Ultrasound 2001;42:7779.
  • 10
    Jones PD, de Lorimier LP, Kitchell BE, et al. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma. J Am Anim Hosp Assoc 2003;39:463467.
  • 11
    LeBlanc AK, LaDue TA, Turrel JM, et al. Unexpected toxicity following use of Gemcitabine as a radiosensitizer in head and neck carcinomas: A veterinary radiation therapy oncology group pilot study. Vet Radiol Ultrasound 2004;45:466470.
  • 12
    Larue SM, Vail DM, Ogilvie GK, et al. Shrinking-field radiation therapy in combination with mitoxantrone chemotehrapy for the treatment of oral squamous cell carcinoma in the cat. 11th Annual Conference of the Veterinary Cancer Society, 1991;99.
  • 13
    Evans SM, LaCreta F, Helfand S, et al. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1991;20:703708.
  • 14
    Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:112.
  • 15
    Nguyen LN, Ang KK. Radiotherapy for cancer of the head and neck: Altered fractionation regimens. Lancet Oncol 2002;3:693701.
  • 16
    Maguire PD, Meyerson MB, Neal CR, et al. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community. Int J Radiat Oncol Biol Phys 2004;58:698704.
  • 17
    Malone JP, Stephens JA, Grecula JC, et al. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Head Neck 2004;26:561572.
  • 18
    Browman GP, Hodson DI, Mackenzie RJ, et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579589.
  • 19
    Fidel JL, Egger E, Blattmann H, et al. Proton irradiation of feline nasal planum squamous cell carcinomas using an accelerated protocol. Vet Radiol Ultrasound 2001;42:569575.
  • 20
    Melzer K, Guscetti F, Rohrer Bley C, et al. Ki67 reactivity in nasal and periocular squamous cell carcinomas in cats treated with electron beam radiation therapy. J Vet Intern Med 2006;20:676681.
  • 21
    Fidel JL, Sellon RK, Houston RK, et al. A nine-day accelerated radiation protocol for feline squamous cell carcinoma. Vet Radiol Ultrasound 2007;48:482485.
  • 22
    Ladue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound 2001;42:475476.
  • 23
    Bradley RL. Selected oral, pharyngeal, and upper respiratory conditions in the cat. Oral tumors, nasopharyngeal and middle ear polyps, and chronic rhinitis and sinusitis. Vet Clin North Am Small Anim Pract 1984;14:11731184.
  • 24
    Northrup NC, Selting KA, Rassnick KM, et al. Outcomes of cats with oral tumors treated with mandibulectomy: 42 cases. J Am Anim Hosp Assoc 2006;42:350360.
  • 25
    Wood C. Combination coarse fractionated radiation therapy and carboplatin chemotherapy for treatment of feline oral squamous cell carcinoma: Interim analysis. VCS Newsletter 1998, 1–4.
  • 26
    Hayes AM, Adams VJ, Scase TJ, et al. Survival of 54 cats with oral squamous cell carcinoma in United Kingdom general practice. J Small Anim Pract 2007;48:394399.
  • 27
    Fowler JF. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. Clin Oncol (R Coll Radiol) 2007;19:822.
  • 28
    Knapp DW, Richardson RC, DeNicola DB, et al. Cisplatin toxicity in cats. J Vet Intern Med 1987;1:2935.
  • 29
    Kisseberth WC, Vail DM, Yaissle J, et al. Phase I clinical evaluation of carboplatin in tumor-bearing cats: A Veterinary Cooperative Oncology Group study. J Vet Intern Med 2008;22:8388.
  • 30
    Schmidt BR, Glickman NW, DeNicola DB, et al. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 2001;218:17831786.
  • 31
    Sklenicka S, Gardiner S, Dierks EJ, et al. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: Does surgical salvage affect outcome? J Oral Maxillofac Surg 2010;68:12701275.